FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain

Oncogene

Volumn 22, Issue 21, 2003, Pages 3319-3329

  Maurer, Philippe ^a   T'Sas, France ^a   Coutte, Laurent ^b   Callens, Nathalie ^a,b   Brenner, Carmen ^a   Van Lint, Carine ^a   De Launoit, Yvan ^a,b   Baert, Jean Luc ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

Ets; Repression; Transcription factor

Indexed keywords

ALANINE; CELL PROTEIN; FIFTH EWING VARIANT PROTEIN; HISTONE DEACETYLASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; NUCLEAR PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRICHOSTATIN A; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FEV PROTEIN, HUMAN; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL CLONE; CELL GROWTH; CELL STRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; GENE FUNCTION; GENE LOCATION; GENE MAPPING; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEGAKARYOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPRESSOR GENE; TRANSCRIPTION REGULATION; ANIMAL; CELL CULTURE; CELL LINE; CELL NUCLEUS; CELL STRAIN COS1; CHEMISTRY; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; RABBIT;

ANIMALIA; FROG ERYTHROCYTIC VIRUS;

ALANINE; ANIMALS; CELL LINE; CELL NUCLEUS; COS CELLS; DNA-BINDING PROTEINS; GENE SILENCING; HUMANS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RABBITS; REPRESSOR PROTEINS; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0038621380     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206572     Document Type: Article

References (40)

1. Baert JL, Beaudoin C, Coutte L and de Launoit Y. (2002). J. Biol. Chem., 277, 1002-1012.
2. Baert JL, Monte D, Musgrove EA, Albagli O, Sutherland RL and de Launoit Y. (1997). Int. J. Cancer, 70, 590-597.
3. Bird AP and Wolffe AP. (1999). Cell, 99, 451-454.
4. Briata P, Ilengo C, Van DeWerken R and Corte G. (1997). FEBS Lett., 402, 131-135.
5. Chakrabarti SR and Nucifora G. (1999). Biochem. Biophys. Res. Commun., 264, 871-877.
6. Courey AJ and Jia S. (2001). Genes Dev., 15, 2786-2796.
7. Coutte L, Monte D, Imai K, Pouilly L, Dewitte F, Vidaud M, Adamski J, Baert JL and de Launoit Y. (1999). Oncogene, 18, 6278-6286.
8. Criqui-Filipe P, Ducret C, Maira SM and Wasylyk B. (1999). EMBO J., 18, 3392-3403.
9. de Launoit Y, Audette M, Pelczar H, Plaza S and Baert JL. (1998). Oncogene, 16, 2065-2073.
10. de Launoit Y, Chotteau-Lelievre A, Beaudoin C, Coutte L, Netzer S, Brenner C, Huvent I and Baert JL. (2000). Adv. Exp. Med. Biol., 480, 107-116.
11. Defossez PA, Baert JL, Monnot M and de Launoit Y. (1997). Nucleic Acids Res., 25, 4455-4463.
12. Ducret C, Maira SM, Lutz Y and Wasylyk B. (2000). Oncogene, 19, 5063-5072.
13. Fenrick R, Amann JM, Lutterbach B, Wang L, Westendorf JJ, Downing JR and Hiebert SW. (1999). Mol. Cell. Biol., 19, 6566-6574.
14. Fyodorov D, Nelson T and Deneris E. (1998). J. Neurobiol., 34, 151-163.
15. Goodman FR, Mundlos S, Muragaki Y, Donnai D, Giovannucci-Uzielli ML, Lapi E, Majewski F, McGaughran J, McKeown C, Reardon W, Upton J, Winter RM, Olsen BR and Scambler PJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 7458-7463.
16. Graves BJ and Petersen JM. (1998). Adv. Cancer Res., 75, 1-55.
17. Guidez F, Petrie K, Ford AM, Lu H, Bennett CA, MacGregor A, Hannemann J, Ito Y, Ghysdael J, Greaves M, Wiedemann LM and Zelent A. (2000). Blood, 96, 2557-2561.
18. Hanna-Rose W and Hansen U. (1996). Trends Genet., 12, 229-234.
19. Hendricks T, Francis N, Fyodorov D and Deneris ES. (1999). J. Neurosci., 19, 10348-10356.
20. Janknecht R. (1996). Mol. Cell. Biol., 16, 1550-1556.
21. Janknecht R, Monte D, Baert JL and de Launoit Y. (1996). Oncogene, 13, 1745-1754.
22. Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA, Gunther CV, Nye JA and Graves BJ. (1990). Genes Dev., 4, 1451-1453.
23. Laget MP, Defossez PA, Albagli O, Baert JL, Dewitte F, Stehelin D and de Launoit Y. (1996). Oncogene, 12, 1325-1336.
24. Lemercier C, Verdel A, Galloo B, Curtet S, Brocard MP and Khochbin S. (2000). J. Biol. Chem., 275, 15594-15599.
25. Li R, Pei H, Watson DK and Papas TS. (2000). Oncogene, 19, 745-753.
26. Lopez RG, Carron C, Oury C, Gardellin P, Bernard O and Ghysdael J. (1999). J. Biol. Chem., 274, 30132-30138.
27. Maira SM, Wurtz JM and Wasylyk B. (1996). EMBO J., 15, 5849-5865.
28. Maroulakou IG and Bowe DB. (2000). Oncogene, 19, 6432-6442.
29. Mavrothalassitis G and Ghysdael J. (2000). Oncogene, 19, 6524-6532.
30. Monte D, Baert JL, Defossez PA, de Launoit Y and Stehelin D. (1994). Oncogene, 9, 1397-1406.
31. Monte D, Coutte L, Baert JL, Angeli I, Stehelin D and de Launoit Y. (1995). Oncogene, 11, 771-779.
32. O'Neill EM, Rebay I, Tjian R and Rubin GM. (1994). Cell, 78, 137-147.
33. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H and Delattre O. (1997). Oncogene, 14, 1159-1164.
34. Pfaar H, von Holst A, Vogt Weisenhorn DM, Brodski C, Guimera J and Wurst W. (2002). Dev. Genes Evol., 212, 43-46.
35. Ray-Gallet D, Mao C, Tavitian A and Moreau-Gachelin F. (1995). Oncogene, 11, 303-313.
36. Sgouras DN, Athanasiou MA, Beal Jr GJ, Fisher RJ, Blair DG and Mavrothalassitis GJ. (1995). EMBO J., 14, 4781-4793.
37. Sharrocks AD. (2001). Nat. Rev. Mol. Cell. Biol., 2, 827-837.
38. Sieweke MH, Tekotte H, Frampton J and Graf T. (1996). Cell, 85, 49-60.
39. Xing X, Wang SC, Xia W, Zou Y, Shao R, Kwong KY, Yu Z, Zhang S, Miller S, Huang L and Hung MC. (2000). Nat. Med., 6, 189-195.
40. Yeung KC, Inostroza JA, Mermelstein FH, Kannabiran C and Reinberg D. (1994). Genes Dev., 8, 2097-2109.